Hereditary Angioedema Market: Global Size, share, Growth, Industry Demand and Analysis Forecasts to 2021- MarketReportsOnline

PUNE, India, July 3, 2017 /PRNewswire-iReach/ -- Hereditary Angioedema (HAE) is a rare hereditary disease caused by a genetic deficiency in a gene known as C1 inhibitor (C1-INH). It is characterized by attacks of edema (swelling). These are unpredictable and can affect various areas of the body including the stomach, hands, feet, arms, legs, genitals, throat, and face.

Complete report on Hereditary Angioedema market spread across 66 pages with providing 4 company profiles, 5 tables and 32 charts is now available at http://www.marketreportsonline.com/608604.html.

Depending on the severity of the disease, some people can have many attacks each month, while others go months without an attack.

Company Coverage of Hereditary Angioedema Market:Shire Plc., CSL Limited, Pharming Group N.V. & BioCryst Pharmaceuticals Inc.

During an HAE attack, swelling can happen in a variety of places. This includes the hands, feet, genitals, gastrointestinal (GI) tract, and throat. Symptoms last about 2 to 5 days and then slowly decrease. Although people are born with a genetic defect, the symptoms start in childhood and worsen during teenage years. Many people do not know they have HAE until they are diagnosed in adulthood.

There are three types of hereditary angioedema, called type I, II, and III, which can be distinguished by their underlying causes and levels of a protein called C1 inhibitor in the blood. The classification of HAE into 3 types is based on what problem the genetic defect causes. Treatment of HAE relies on long–term prophylaxis, short–term prophylaxis, and the treatment of acute attacks. The long–term goal is to minimize the frequency and severity of angioedema episodes.

Purchase a copy of this "Global Hereditary Angioedema Market (2017-2021 Edition)" research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=608604.

The global hereditary angioedema market is set to experience favourable growth driven by factors such as increasing diagnosis of hereditary angioedema & rising health care expenditure. Further, the scope of growth for this market will be broadened by increasing uptake of prophylaxis therapy and global economic development. The major trends that can be observed in this market include introduction of novel drugs, increasing awareness for HAE and oral medication for HAE attacks.

The report "Global Hereditary Angioedema Market: Industry Analysis & Outlook (2017-2021)" analyses the development of this market, with focus on the U.S. and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players Shire Plc., CSL Limited, Pharming Group N.V. & BioCryst Pharmaceuticals Inc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global Hereditary Angioedema market along with the study of the regional markets.

major Points from Table of Contents:

1. Overview

1.1 Introduction1.2 Symptoms1.3 Types of HAE1.4 Treatment Options

2. Global Hereditary Angioedema Market

2.1 Global Hereditary Angioedema Market Forecast by Value

2.2 Global Hereditary Angioedema Market by Drug

2.3 Global Hereditary Angioedema Drug Revenue

3.1 The U.S.3.2 Europe

4. Market Dynamics

4.1 Growth Drivers

4.2 Key Trends & Developments

4.3 Challenges

5.1 Global Market

6. Company Profiles

Explore more pharmaceuticals market research as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-market-research.html.

About Us:

MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Media Contact:Ritesh Tiwari, MarketReportsOnline, + 1 888 391 5441, sales@marketreportsonline.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Market Reports Online